Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
EEG findings in Lennox-Gastaut syndrome: Pursuing a moving target
Juliann M Paolicchi1, Otakhon A Matchanov2
1Department of Neurology, Northwell Health, USA; Department of Neurology and Pediatrics, Zucher School of Medicine at Hofstra/Northwell, USA.
Abstract:
Lennox-Gastaut Syndrome (LGS) is a life-long, drug-resistant developmental epileptic encephalopathy (DEE) that develops in young children between 18 and 24 months of age and up to 18 years of age. The overall incidence is estimated at 0.1 to 0.28 per 100,000 people per year and a lifetime prevalence at age 10 of about 0.26 per 1,000 children. LGS accounts for 1-2 % of all epilepsy cases and 2-5 % of childhood epilepsies, with a higher ratio of males. The disruption of LGS on the lives of patients and their caretakers is considerable given its chronic nature, the injury from the seizures, the need for a high degree of medical supervision, and the toll the syndrome takes on the patients' cognitive and neurologic development. There is variability in the literature on the overall incidence of LGS due to changes in the definitions in past classifications regarding age of inclusion, mandatory seizure types, and mandatory EEG findings. This review focuses on the evolution of the ictal and interictal EEG findings over the course of the syndrome and the developing nature of the seizure types.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
09:00Investigating the Function of Deep Cortical and Subcortical Structures Using Stereotactic Electroencephalography: Lessons from the Anterior Cingulate Cortex
Published on: April 15, 2015